Literature DB >> 8330033

A simple severity of disease index for systemic lupus erythematosus.

J D Katz1, J L Senecal, C Rivest, J R Goulet, N Rothfield.   

Abstract

Although indices of activity for systemic lupus erythematosus have been developed and validated, a disease staging system requires the measurement of severity as well. We have constructed such a scale, the Lupus Severity of Disease Index (Lupus SDI). Accepted clinical, pathologic and physiologic classification schemes were employed to validate this index at two separate research institutions. The Lupus SDI allows homogenization of patient populations for the purposes of research and, possibly, for case mix adjustment.

Entities:  

Mesh:

Year:  1993        PMID: 8330033     DOI: 10.1177/096120339300200210

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  19 in total

1.  Tobacco smoking is an independent factor associated with retinal damage in systemic lupus erythematosus: a cross-sectional and retrospective study.

Authors:  Iñigo Rúa-Figueroa; Celia Erausquin; Celia Rua-Figueroa; Jesús González-Martín; Antonio Naranjo; Soledad Ojeda; Félix Francisco; Juan C Quevedo; Laura Cáceres; Ruben López; Martin Greco; Irene Altabás-González; Yanira Pérez; Francisco Rubiño; Carlos Rodríguez-Lozano
Journal:  Rheumatol Int       Date:  2019-11-27       Impact factor: 2.631

2.  Health-related quality of life in patients with systemic lupus erythematosus: a Spanish study based on patient reports.

Authors:  J A Román Ivorra; N Fernández-Llanio-Comella; A San-Martín-Álvarez; P Vela-Casasempere; I Saurí-Ferrer; S González-de-Julián; D Vivas-Consuelo
Journal:  Clin Rheumatol       Date:  2019-02-28       Impact factor: 2.980

3.  B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE).

Authors:  P P Sfikakis; R Oglesby; P Sfikakis; G C Tsokos
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

4.  Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences.

Authors:  Íñigo Rúa-Figueroa; Patricia Richi; Francisco Javier López-Longo; María Galindo; Jaime Calvo-Alén; Alejandro Olivé-Marqués; Estíbaliz Loza-Santamaría; Sabina Pérez Vicente; Celia Erausquin; Eva Tomero; Loreto Horcada; Esther Uriarte; Ana Sánchez-Atrio; José Rosas; Carlos Montilla; Antonio Fernández-Nebro; Manuel Rodríguez-Gómez; Paloma Vela; Ricardo Blanco; Mercedes Freire; Lucía Silva; Elvira Díez-Álvarez; Mónica Ibáñez-Barceló; Antonio Zea; Javier Narváez; Víctor Martínez-Taboada; José Luis Marenco; Mónica Fernández de Castro; Olaia Fernández-Berrizbeitia; José Ángel Hernández-Beriain; Marian Gantes; Blanca Hernández-Cruz; José J Pérez-Venegas; Ángela Pecondón; Carlos Marras; Patricia Carreira; Gema Bonilla; Vicente Torrente; Iván Castellví; Juan Alegre; Mireia Moreno; Enrique Raya; Paloma García de la Peña; Tomás Vázquez; Ángeles Aguirre; Víctor Quevedo; José M Pego-Reigosa
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

5.  Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry.

Authors:  Natalia Mena-Vázquez; Antonio Fernández-Nebro; José María Pego-Reigosa; María Galindo; Ana Melissa-Anzola; Esther Uriarte-Isacelay; Alejandro Olivé-Marqués; Elena Aurrecoechea; Mercedes Freire; Eva Tomero; María Jesús García-Villanueva; Claudia Stoye; Esteban Salas-Heredia; Jose Antonio Bernal-Vidal; Eva Salgado; Ricardo Blanco; Francisco Javier Novoa; Mónica Ibáñez-Barcelo; Vicente Torrente-Segarra; Javier Narvaez; Joan Calvet; Clara Moriano Morales; Tomas Ramon Vazquez-Rodriguez; Paloma Garcia de la Peña; Cristina Bohórquez; José Luis Andreu-Sánchez; Tatiana Cobo-Ibañez; Gema Bonilla; Nuria Lozano-Rivas; Carlos Montilla; Francisco Javier Toyos; Jose Luis Marenco De la Fuente; Lorena Expósito; María Esther Ruiz-Lucea; Elia Vals; Javier Manero-Ruiz; Jose A Bernal-Vidal; Iñigo Rua-Figueroa
Journal:  Rheumatology (Oxford)       Date:  2020-08-01       Impact factor: 7.580

6.  Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry.

Authors:  Antonio Fernández-Nebro; Íñigo Rúa-Figueroa; Francisco J López-Longo; María Galindo-Izquierdo; Jaime Calvo-Alén; Alejandro Olivé-Marqués; Carmen Ordóñez-Cañizares; María A Martín-Martínez; Ricardo Blanco; Rafael Melero-González; Jesús Ibáñez-Rúan; José Antonio Bernal-Vidal; Eva Tomero-Muriel; Esther Uriarte-Isacelaya; Loreto Horcada-Rubio; Mercedes Freire-González; Javier Narváez; Alina L Boteanu; Gregorio Santos-Soler; José L Andreu; José M Pego-Reigosa
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.817

7.  Development and validation of a simple lupus severity index using ACR criteria for classification of SLE.

Authors:  Ghalib A Bello; Michael A Brown; Jennifer A Kelly; Aikaterini Thanou; Judith A James; Courtney G Montgomery
Journal:  Lupus Sci Med       Date:  2016-03-10

8.  Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER).

Authors:  María Galindo-Izquierdo; Esther Rodriguez-Almaraz; José M Pego-Reigosa; Francisco J López-Longo; Jaime Calvo-Alén; Alejandro Olivé; Antonio Fernández-Nebro; Víctor Martinez-Taboada; Paloma Vela-Casasempere; Mercedes Freire; Francisco J Narváez; José Rosas; Mónica Ibáñez-Barceló; Esther Uriarte; Eva Tomero; Antonio Zea; Loreto Horcada; Vicenç Torrente; Iván Castellvi; Joan Calvet; Raúl Menor-Almagro; María A Aguirre Zamorano; Enrique Raya; Elvira Díez-Álvarez; Tomás Vázquez-Rodríguez; Paloma García de la Peña; Atusa Movasat; José L Andreu; Patricia Richi; Carlos Marras; Carlos Montilla-Morales; Blanca Hernández-Cruz; José L Marenco de la Fuente; María Gantes; Eduardo Úcar; Juan J Alegre-Sancho; Javier Manero; Jesús Ibáñez-Ruán; Manuel Rodríguez-Gómez; Víctor Quevedo; José Hernández-Beriaín; Lucía Silva-Fernández; Fernando Alonso; Sabina Pérez; Iñigo Rúa-Figueroa
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

9.  Vitamin D Deficiency in Egyptian Systemic Lupus Erythematosus Patients: How Prevalent and Does It Impact Disease Activity?

Authors:  Nouran M Abaza; Reem M El-Mallah; Asmaa Shaaban; Sameh A Mobasher; Khaled F Al-Hassanein; Amr A Abdel Zaher; Rania H El-Kabarity
Journal:  Integr Med Insights       Date:  2016-09-26

10.  Cell-bound complement activation products associate with lupus severity in SLE.

Authors:  Cristina Arriens; Roberta Vezza Alexander; Sonali Narain; Amit Saxena; Christopher E Collins; Daniel J Wallace; Elena Massarotti; John Conklin; Kenneth C Kalunian; Chaim Putterman; Rosalind Ramsey-Goldman; Jill P Buyon; Anca Askanase; Richard A Furie; Judith A James; Ghalib A Bello; Susan Manzi; Joseph Ahearn; Tyler O'Malley; Arthur Weinstein; Thierry Dervieux
Journal:  Lupus Sci Med       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.